Skip to main content

Table 1 Clinical characters, risk factor, and symptoms of the cohort

From: Clinical impact of circulating miR-26a, miR-191, and miR-208b in plasma of patients with acute myocardial infarction

Clinicopathological features

AMI cases (n = 87)

Normal cases (n = 87)

P

Age (year)

56.93 ± 9.17

57.28 ± 10.82

>0.05

Male/Female

64/23

62/25

>0.05

Hypertension (Y/N)

38/49

40/47

>0.05

Hypercholesterolemia (Y/N)

9/78

14/73

>0.05

Diabetes (Y/N)

18/69

20/67

>0.05

Alcohol drinking (Y/N)

18/69

17/60

>0.05

Smoking (Y/N)

33/54

39/48

>0.05

Systolic blood pressure (mmHg)

123.88 ± 18.51

130.7 ± 19.0

0.005

Diastolic blood pressure (mmHg)

74.68 ± 11.70

80.82 ± 15.8

0.015

Heart rate (beats per minute)

74.20 ± 13.03

73.53 ± 13.57

>0.05

Cholesterol (mmol/L)

3.79 ± 0.99

3.79 ± 0.91

>0.05

Triglyceride (mmol/L)

1.39 ± 1.07

1.35 ± 0.92

>0.05

HDL (mmol/L)

1.02 ± 0.21

1.09 ± 0.18

>0.05

LDL (mmol/L)

2.47 ± 0.97

2.51 ± 0.88

>0.05

White blood cells (×109/L)

9.74 ± 3.43

6.93 ± 1.19

<0.001

BUN (mmol/L)

6.05 ± 3.55

5.81 ± 1.97

>0.05

CK-MB(U/L)

53.28 ± 8.17

15.61 ± 9.87

<0.001

Troponin T (ng/mL)

1.43 ± 1.76

0.05 ± 0.17

<0.001

  1. AMI acute myocardial infarction, HDL high-density lipoprotein, LDL low-density lipoprotein, BUN blood urea nitrogen, CK-MB creatine kinase-MB, P comparison between AMI patients and healthy controls
  2. Data are expressed as mean ± standard
  3. The results with a significant difference were marked in italics